815 - Long-Term Efficacy and Safety of CT-P13 after Switching from Originator Infliximab: Exploratory Subgroup Analyses in IBD in the Nor-Switch Extension Trial
暂无分享,去创建一个
Inge Christoffer Olsen | J. Jahnsen | I. Berset | T. Kvien | J. Sexton | N. Bolstad | K. Lundin | G. Goll | E. Haavardsholm | C. Mork | Kristin K. Joergensen